Literature DB >> 21205222

Predictors of mortality in verapamil overdose: usefulness of serum verapamil concentrations.

Bruno Mégarbane1, Souheil Karyo, Khalid Abidi, Brigitte Delhotal-Landes, Mounir Aout, Philippe Sauder, Frédéric J Baud.   

Abstract

Verapamil poisoning may result in life-threatening cardiovascular morbidities and fatalities. To date, prognosticators of mortality have been poorly investigated and the use of serum verapamil concentration for prognosis remains unclear. We aimed to evaluate the ability of usual clinical and laboratory parameters including serum verapamil concentrations measured on admission to predict outcome (survival versus death) in verapamil poisoning. We reviewed the medical records of all intentional and symptomatic verapamil poisonings admitted over 8 years to two medical intensive care units. Clinical and laboratory parameters were measured in 65 patients, and final outcomes of survival or death recorded. A multivariable analysis was conducted to evaluate the prognostic values of recorded parameters. Life-threatening complications of verapamil poisonings included shock (62%), atrioventricular blocks (24%), sinoatrial blocks (20%), acute respiratory distress syndrome (19%) and cardiac arrest (11%) resulting in death (8%). Verapamil concentration measured on intensive care unit admission was the only independent factor associated with mortality (p = 0.01). The optimal verapamil cut-off point was 5.0 μM (100% sensitivity, 91% specificity), which conferred a 2.76-times increase in odds of fatality. In conclusion, cardiovascular monitoring and assessment of organ failure are vital in symptomatic verapamil poisonings. The serum verapamil concentration has excellent prognostic ability for predicting fatality in verapamil overdose.
© 2011 The Authors. Basic & Clinical Pharmacology & Toxicology © 2011 Nordic Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21205222     DOI: 10.1111/j.1742-7843.2010.00666.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  4 in total

1.  Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.

Authors:  Itsuro Kazama; Tsutomu Tamada; Masahiro Tachi
Journal:  Inflamm Res       Date:  2015-07-24       Impact factor: 4.575

2.  New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T Cells.

Authors:  Getahun Abate; Peter G Ruminiski; Malkeet Kumar; Kawaljit Singh; Fahreta Hamzabegovic; Daniel F Hoft; Christopher S Eickhoff; Asmir Selimovic; Mary Campbell; Kelly Chibale
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

3.  Comparison of Effects of Separate and Combined Sugammadex and Lipid Emulsion Administration on Hemodynamic Parameters and Survival in a Rat Model of Verapamil Toxicity.

Authors:  Serkan Tulgar; Halil Cihan Kose; Isılay Demir Piroglu; Evvah Karakilic; Nagihan Gozde Ates; Ahmet Demir; Ruken Gergerli; Selin Guven; Mustafa Devrim Piroglu
Journal:  Med Sci Monit       Date:  2016-03-25

4.  Antiarrhythmic calcium channel blocker verapamil inhibits trek currents in sympathetic neurons.

Authors:  S Herrera-Pérez; L Rueda-Ruzafa; A Campos-Ríos; D Fernández-Fernández; J A Lamas
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.